Genetic testing aims to improve drug satisfaction in underserved communities

NCT ID NCT05141019

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether giving patients genetic test results early can help doctors choose better medications. About 492 adults with at least three prescriptions will be randomly assigned to get immediate or delayed genetic testing. The goal is to see if this approach improves how satisfied patients feel with their medications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

pharmacogenetic testing

What this could lead to

If successful, this could show that preemptive genetic testing helps personalize medications and improve patient satisfaction, especially in underserved groups.

What could go wrong

This is an early-stage feasibility study with 492 participants, so results may not apply broadly. The main outcome is patient satisfaction, not clinical health improvements.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for USE OF PRESCRIPTION MEDICATIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • UF Health at the University of Florida

    Gainesville, Florida, 32610, United States